IOPIDINE
Details
- Status
- Prescription
- First Approved
- 1987-12-31
- Routes
- OPHTHALMIC
- Dosage Forms
- SOLUTION/DROPS
IOPIDINE Approval History
What IOPIDINE Treats
3 FDA approvalsOriginally approved for its first indication in 1987 . Covers 3 distinct patient populations.
- Other (3)
Other
(3 approvals)- • Approved indication (Dec 1987)
- • Approved indication (Dec 1989)
- • Approved indication (Jul 1993) Priority
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
IOPIDINE FDA Label Details
ProIndications & Usage
FDA Label (PDF)IOPIDINE 1% Ophthalmic Solution is indicated to control or prevent post-surgical elevations in IOP that occur in patients after argon laser trabeculoplasty, argon laser iridotomy or Nd:YAG posterior capsulotomy.
Want competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.